home / stock / qgen / qgen quote
Last: | $41.65 |
---|---|
Change Percent: | -0.05% |
Open: | $41.1 |
Close: | $41.65 |
High: | $41.68 |
Low: | $41.06 |
Volume: | 1,406,780 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$41.65 | $41.1 | $41.65 | $41.68 | $41.06 | 1,406,780 | 04-26-2024 |
$41.08 | $40.87 | $41.08 | $41.09 | $40.555 | 1,223,270 | 04-25-2024 |
$41.52 | $41.72 | $41.52 | $41.82 | $41.25 | 816,213 | 04-24-2024 |
$41.89 | $41.28 | $41.89 | $41.94 | $41.19 | 971,222 | 04-23-2024 |
$41.22 | $40.98 | $41.22 | $41.35 | $40.8 | 1,253,769 | 04-22-2024 |
$40 | $39.64 | $40 | $40.14 | $39.64 | 1,107,980 | 04-19-2024 |
$39.47 | $39.31 | $39.47 | $39.56 | $39.03 | 951,915 | 04-18-2024 |
$39.23 | $39.54 | $39.23 | $39.6 | $39.18 | 795,969 | 04-17-2024 |
$39.32 | $39.47 | $39.32 | $39.51 | $39.14 | 737,281 | 04-16-2024 |
$39.67 | $40.44 | $39.67 | $40.48 | $39.56 | 551,514 | 04-15-2024 |
$40.18 | $40.78 | $40.18 | $40.93 | $40.14 | 641,940 | 04-12-2024 |
$41.17 | $41.63 | $41.17 | $41.67 | $40.885 | 528,769 | 04-11-2024 |
$41.18 | $41.31 | $41.18 | $41.54 | $41.02 | 909,211 | 04-10-2024 |
$41.97 | $41.33 | $41.97 | $41.98 | $41.33 | 863,744 | 04-09-2024 |
$41.5 | $41.27 | $41.5 | $41.55 | $41.22 | 1,147,778 | 04-08-2024 |
$41.17 | $40.93 | $41.17 | $41.24 | $40.84 | 1,632,481 | 04-05-2024 |
$41.11 | $41.47 | $41.11 | $41.8 | $41.09 | 940,114 | 04-04-2024 |
$41.91 | $41.33 | $41.91 | $42.03 | $41.3 | 994,708 | 04-03-2024 |
$42.21 | $42.48 | $42.21 | $42.57 | $42.14 | 762,859 | 04-02-2024 |
$42.49 | $43.02 | $42.49 | $43.42 | $42.35 | 564,571 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Qiagen N.V. Company Name:
QGEN Stock Symbol:
NYSE Market:
Venlo, the Netherlands, April 24, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world’s leading infectious d...
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date / time: Monday, April 29, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05&...
Venlo, the Netherlands, April 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new approach for liquid biopsy. These thr...